| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q0084 |
Chemotherapy administration by infusion technique only, per visit |
12,546 |
5,225 |
$1.11M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
9,157 |
4,477 |
$742K |
| 96415 |
|
6,101 |
3,208 |
$412K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,901 |
3,628 |
$284K |
| 96417 |
|
3,965 |
2,521 |
$231K |
| J9035 |
Injection, bevacizumab, 10 mg |
44 |
25 |
$207K |
| J9171 |
Injection, docetaxel, 1 mg |
67 |
52 |
$179K |
| 96367 |
|
3,634 |
2,007 |
$72K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,405 |
825 |
$65K |
| 96416 |
|
822 |
522 |
$61K |
| 96402 |
|
1,301 |
1,177 |
$34K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
403 |
322 |
$32K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
172 |
144 |
$27K |
| J1453 |
Injection, fosaprepitant, 1 mg |
97 |
49 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,647 |
812 |
$18K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
641 |
333 |
$13K |
| J9045 |
Injection, carboplatin, 50 mg |
192 |
128 |
$12K |
| 96523 |
|
567 |
385 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,489 |
2,016 |
$7K |
| J3489 |
Injection, zoledronic acid, 1 mg |
118 |
99 |
$7K |
| J9190 |
Injection, fluorouracil, 500 mg |
285 |
156 |
$6K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
125 |
76 |
$4K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
28 |
12 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12 |
12 |
$886.56 |